Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 2

Conditions

Lymphoma 34Leukemia 34Lymphoma, Follicular 27Melanoma 25Leukemia, Lymphocytic, Chronic, B-Cell 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma, Non-Hodgkin 20Leukemia, Myeloid, Acute 20Multiple Myeloma 18Breast Neoplasms 18Lymphoma, Large B-Cell, Diffuse 17Prostatic Neoplasms 15Lymphoma, Mantle-Cell 15Lymphoma, Large-Cell, Immunoblastic 15Neuroblastoma 14Neoplasms, Plasma Cell 13Myelodysplastic Syndromes 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Hodgkin Disease 13Burkitt Lymphoma 13Leukemia, Myeloid, Chronic-Phase 12Neoplasm Metastasis 11Lymphoma, B-Cell, Marginal Zone 11Lung Neoplasms 10Glioblastoma 9Carcinoma, Non-Small-Cell Lung 9Myeloproliferative Disorders 8Leukemia, Myeloid, Accelerated Phase 8Ovarian Neoplasms 7Gliosarcoma 7

Interventions

Cyclophosphamide 18Etoposide 12Cisplatin 11Temozolomide 10Vincristine 9Radiotherapy 9Magnetic Resonance Spectroscopy 9Filgrastim 8Irinotecan 7Carboplatin 7X-Rays 6Phantoms, Imaging 6Topotecan 5Specimen Handling 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Thiotepa 4Radiation 4Lomustine 4Biopsy 4Bevacizumab 4tipifarnib 3sargramostim 3palbociclib 3Methotrexate 3HhAntag691 3Chemotherapy, Adjuvant 3ulixertinib 2tazemetostat 2sonidegib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Medulloblastoma × sargramostim × Clear all
NCT00002594 2014-07-24

Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
31 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

NCT00014573 2013-04-08

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

NCT00008008 2013-02-04

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡